US Stock MarketDetailed Quotes

Keros Therapeutics (KROS)

Watchlist
  • 11.670
  • -0.050-0.43%
Close Apr 17 15:59 ET
  • 11.900
  • +0.230+1.97%
Post 20:01 ET
230.10MMarket Cap5.07P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Keros Therapeutics (KROS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
166.83%107.51M
40.68%-27.29M
110.65%3.25M
25.57%-29.62M
461.69%161.17M
-29.20%-160.87M
-80.71%-46.01M
10.25%-30.5M
-29.09%-39.8M
-30.16%-44.56M
Net income from continuing operations
146.44%87.01M
49.03%-23.46M
86.25%-7.28M
32.17%-30.7M
444.32%148.45M
-22.46%-187.35M
-14.37%-46.03M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
Operating gains losses
---13K
--1K
--0
----
----
----
----
----
----
----
Depreciation and amortization
22.78%1.51M
20.48%400K
25.80%395K
20.92%370K
24.19%344K
50.80%1.23M
34.41%332K
49.52%314K
60.21%306K
65.87%277K
Other non cash items
32.42%2.41M
8.74%622K
8.17%609K
71.97%595K
72.27%584K
17.27%1.82M
70.75%572K
65.10%563K
-2.26%346K
-35.06%339K
Change In working capital
-5.89%-12.11M
-20.55%-12.16M
-56.60%5.54M
-111.50%-8.42M
128.91%2.93M
-331.58%-11.44M
-246.64%-10.09M
435.49%12.76M
-336.04%-3.98M
-110.60%-10.13M
-Change in receivables
-18.31%-3.08M
1.23%-2.33M
3,309.38%12.32M
564.41%1.48M
-17,428.92%-14.55M
-1,717.48%-2.6M
-1,546.15%-2.35M
---384K
--222K
---83K
-Change in prepaid assets
139.33%4.02M
102.69%141K
-24.50%4.43M
19.89%-5.1M
201.45%4.54M
-10.05%-10.22M
-1,073.28%-5.25M
237.86%5.87M
-327.54%-6.37M
-9.92%-4.48M
-Change in payables and accrued expense
-585.83%-13.13M
-482.54%-9.27M
-239.52%-9.92M
-196.14%-2.42M
259.11%8.48M
-60.66%2.7M
-123.31%-1.59M
7,631.52%7.11M
316.75%2.51M
-713.89%-5.33M
-Change in other current assets
51,500.00%2.06M
--0
--0
1,880.77%463K
--1.59M
99.16%-4K
1.88%-469K
--491K
---26K
--0
-Change in other working capital
-49.85%-1.98M
-64.94%-701K
-291.24%-1.3M
-777.16%-2.84M
1,291.67%2.86M
-443.75%-1.32M
-429.46%-425K
-190.93%-331K
-1,100.00%-324K
-192.68%-240K
Cash from discontinued investing activities
Operating cash flow
166.83%107.51M
40.68%-27.29M
110.65%3.25M
25.57%-29.62M
461.69%161.17M
-29.20%-160.87M
-80.71%-46.01M
10.25%-30.5M
-29.09%-39.8M
-30.16%-44.56M
Investing cash flow
Cash flow from continuing investing activities
19.68%-1.55M
53.63%-134K
65.80%-132K
-132.26%-720K
40.27%-565K
21.63%-1.93M
46.58%-289K
29.82%-386K
0.32%-310K
10.92%-946K
Net PPE purchase and sale
19.68%-1.55M
53.63%-134K
65.80%-132K
-132.26%-720K
40.27%-565K
21.63%-1.93M
46.58%-289K
29.82%-386K
0.32%-310K
10.92%-946K
Cash from discontinued investing activities
Investing cash flow
19.68%-1.55M
53.63%-134K
65.80%-132K
-132.26%-720K
40.27%-565K
21.63%-1.93M
46.58%-289K
29.82%-386K
0.32%-310K
10.92%-946K
Financing cash flow
Cash flow from continuing financing activities
-196.59%-378.47M
-601.21%-378.63M
-99.91%140K
-99.52%17K
-100.00%4K
118.95%391.82M
9.08%75.54M
54,809.86%155.94M
102.93%3.53M
45.62%156.8M
Net common stock issuance
-198.65%-375M
-613.19%-375.14M
-99.91%138K
--0
--0
116.20%380.13M
6.69%73.1M
--155.07M
--629K
41.03%151.34M
Proceeds from stock option exercised by employees
-97.63%288K
-89.16%265K
-99.80%2K
-99.43%17K
-99.93%4K
276.47%12.14M
204.10%2.45M
224.12%1.01M
70.52%2.97M
1,446.22%5.72M
Net other financing activities
-727.75%-3.76M
----
----
----
----
-382.98%-454K
--0
---130K
---65K
---259K
Cash from discontinued financing activities
Financing cash flow
-196.59%-378.47M
-601.21%-378.63M
-99.91%140K
-99.52%17K
-100.00%4K
118.95%391.82M
9.08%75.54M
54,809.86%155.94M
102.93%3.53M
45.62%156.8M
Net cash flow
Beginning cash position
68.91%561.38M
30.59%694.92M
69.91%691.66M
62.74%721.99M
68.91%561.38M
18.54%332.36M
84.06%532.13M
25.89%407.08M
25.77%443.66M
18.54%332.36M
Current changes in cash
-218.99%-272.52M
-1,488.37%-406.06M
-97.40%3.26M
17.10%-30.33M
44.31%160.61M
340.56%229.02M
-32.38%29.25M
465.15%125.06M
-24.41%-36.58M
53.76%111.3M
End cash Position
-48.54%288.86M
-48.54%288.86M
30.59%694.92M
69.91%691.66M
62.74%721.99M
68.91%561.38M
68.91%561.38M
84.06%532.13M
25.89%407.08M
25.77%443.66M
Free cash flow
165.08%105.95M
40.76%-27.43M
110.09%3.12M
24.35%-30.34M
452.93%160.61M
-28.22%-162.8M
-78.07%-46.3M
10.56%-30.89M
-28.80%-40.11M
-28.92%-45.51M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 166.83%107.51M40.68%-27.29M110.65%3.25M25.57%-29.62M461.69%161.17M-29.20%-160.87M-80.71%-46.01M10.25%-30.5M-29.09%-39.8M-30.16%-44.56M
Net income from continuing operations 146.44%87.01M49.03%-23.46M86.25%-7.28M32.17%-30.7M444.32%148.45M-22.46%-187.35M-14.37%-46.03M-34.27%-52.96M-20.67%-45.26M-20.42%-43.11M
Operating gains losses ---13K--1K--0----------------------------
Depreciation and amortization 22.78%1.51M20.48%400K25.80%395K20.92%370K24.19%344K50.80%1.23M34.41%332K49.52%314K60.21%306K65.87%277K
Other non cash items 32.42%2.41M8.74%622K8.17%609K71.97%595K72.27%584K17.27%1.82M70.75%572K65.10%563K-2.26%346K-35.06%339K
Change In working capital -5.89%-12.11M-20.55%-12.16M-56.60%5.54M-111.50%-8.42M128.91%2.93M-331.58%-11.44M-246.64%-10.09M435.49%12.76M-336.04%-3.98M-110.60%-10.13M
-Change in receivables -18.31%-3.08M1.23%-2.33M3,309.38%12.32M564.41%1.48M-17,428.92%-14.55M-1,717.48%-2.6M-1,546.15%-2.35M---384K--222K---83K
-Change in prepaid assets 139.33%4.02M102.69%141K-24.50%4.43M19.89%-5.1M201.45%4.54M-10.05%-10.22M-1,073.28%-5.25M237.86%5.87M-327.54%-6.37M-9.92%-4.48M
-Change in payables and accrued expense -585.83%-13.13M-482.54%-9.27M-239.52%-9.92M-196.14%-2.42M259.11%8.48M-60.66%2.7M-123.31%-1.59M7,631.52%7.11M316.75%2.51M-713.89%-5.33M
-Change in other current assets 51,500.00%2.06M--0--01,880.77%463K--1.59M99.16%-4K1.88%-469K--491K---26K--0
-Change in other working capital -49.85%-1.98M-64.94%-701K-291.24%-1.3M-777.16%-2.84M1,291.67%2.86M-443.75%-1.32M-429.46%-425K-190.93%-331K-1,100.00%-324K-192.68%-240K
Cash from discontinued investing activities
Operating cash flow 166.83%107.51M40.68%-27.29M110.65%3.25M25.57%-29.62M461.69%161.17M-29.20%-160.87M-80.71%-46.01M10.25%-30.5M-29.09%-39.8M-30.16%-44.56M
Investing cash flow
Cash flow from continuing investing activities 19.68%-1.55M53.63%-134K65.80%-132K-132.26%-720K40.27%-565K21.63%-1.93M46.58%-289K29.82%-386K0.32%-310K10.92%-946K
Net PPE purchase and sale 19.68%-1.55M53.63%-134K65.80%-132K-132.26%-720K40.27%-565K21.63%-1.93M46.58%-289K29.82%-386K0.32%-310K10.92%-946K
Cash from discontinued investing activities
Investing cash flow 19.68%-1.55M53.63%-134K65.80%-132K-132.26%-720K40.27%-565K21.63%-1.93M46.58%-289K29.82%-386K0.32%-310K10.92%-946K
Financing cash flow
Cash flow from continuing financing activities -196.59%-378.47M-601.21%-378.63M-99.91%140K-99.52%17K-100.00%4K118.95%391.82M9.08%75.54M54,809.86%155.94M102.93%3.53M45.62%156.8M
Net common stock issuance -198.65%-375M-613.19%-375.14M-99.91%138K--0--0116.20%380.13M6.69%73.1M--155.07M--629K41.03%151.34M
Proceeds from stock option exercised by employees -97.63%288K-89.16%265K-99.80%2K-99.43%17K-99.93%4K276.47%12.14M204.10%2.45M224.12%1.01M70.52%2.97M1,446.22%5.72M
Net other financing activities -727.75%-3.76M-----------------382.98%-454K--0---130K---65K---259K
Cash from discontinued financing activities
Financing cash flow -196.59%-378.47M-601.21%-378.63M-99.91%140K-99.52%17K-100.00%4K118.95%391.82M9.08%75.54M54,809.86%155.94M102.93%3.53M45.62%156.8M
Net cash flow
Beginning cash position 68.91%561.38M30.59%694.92M69.91%691.66M62.74%721.99M68.91%561.38M18.54%332.36M84.06%532.13M25.89%407.08M25.77%443.66M18.54%332.36M
Current changes in cash -218.99%-272.52M-1,488.37%-406.06M-97.40%3.26M17.10%-30.33M44.31%160.61M340.56%229.02M-32.38%29.25M465.15%125.06M-24.41%-36.58M53.76%111.3M
End cash Position -48.54%288.86M-48.54%288.86M30.59%694.92M69.91%691.66M62.74%721.99M68.91%561.38M68.91%561.38M84.06%532.13M25.89%407.08M25.77%443.66M
Free cash flow 165.08%105.95M40.76%-27.43M110.09%3.12M24.35%-30.34M452.93%160.61M-28.22%-162.8M-78.07%-46.3M10.56%-30.89M-28.80%-40.11M-28.92%-45.51M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -